Why Should You Attend:
When the PI signs the FDA form 1572 (for IND studies) or the "Statement of the Investigator (for IDE studies), she / he is signing a legally binding document committing themselves to follow all of the appropriate regulations. The responsibilities are clearly described / outlined in The ICH GCP Guidelines of E6 (4.1 to 4.13).
This training, by a 20-year industry veteran, will cover the regulations and the PI's responsibilities for both drug and device clinical research in a user friendly way.
Areas Covered in the Seminar:
Who Will Benefit:
This webinar will provide valuable assistance to all personnel in:
Madhavi Diwanji, BS, MBA, CCRC is the President of MD Clinical Monitor. She has tremendous experience in the healthcare industry in various roles for the past 20 years. She is well rounded in all aspects of clinical trial as she has been instrumental in healthcare research with a primary focus on cardiology for 8 years.
She has experience with monitoring clinical trials, conducting clinical trials, investigator initiated trials, maintaining multiple Trial Master Files, starting a research program in a hospital, health services research, regulatory /compliance submission and management, grant submission, business development and fundraising. She has successfully worked with different IRBs, CROs and sponsors.She has served on a study coordinator advisory committee of a global Congestive Heart failure clinical trial.
In the FDA form 1572, the Investigator signs an agreement that has 9 statements, 7 of which begin with “I agree”, one with “I have read and understand”, and one with “I will ensure”.
Named in the 1572 is 21 CFR 50 (Protection of Human Subjects), 21 CFR 56 (Institutional Review Boards), and 21 CFR 312 (Investigational New Drug Application / IND). For Device studies, 21 CFR 812 (Investigational Device Exemptions / IDE) is added in place of 21 CFR 312. Additional responsibilities are clearly outlined in the GCP Guidelines of E6 (4) and the Compliance Program Guidance Manual (CPGM) 7348.811. To follow the regulations is Good Clinical Practices (GCP) and common sense. To not know and not follow these regulations is folly.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction